SEC Tracker
Get the app

Personalis PSNL

Personalis reports Q3 2026 results

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Quarterly revenue of $25.6 million
  2. Clinical test revenue of $4.4 million
  3. 13,157 clinical tests performed
  4. Cash position of $190.6 million

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Personalis files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Castle Biosciences CSTL public float $576M, Jun 30, 2025
  2. Celcuity CELC public float $457M, Jun 30, 2025
  3. Fortrea Holdings FTRE public float $448M, Jun 30, 2025
  4. CareDx CDNA public float $1.0B, Jun 30, 2025
  5. Fulgent Genetics FLGT public float $284M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.